ESC Premium Access

State of Affairs: a cautiously optimistic perspective on bioresordable scaffolds

Congress Session

About the speaker

Doctor Gregg Stone

Icahn School of Medicine at Mount Sinai, New York (United States of America)
12 presentations
0 follower

4 more presentations in this session

State of the Art: does DES type impact long-term outcome and, potentially, DAPT duration?

Speaker: Professor S. Massberg (Munich, DE)

Thumbnail

Four-year clinical outcome following randomised use of zotarolimus-eluting stents versus everolimus-eluting stents in all-comers: insights from the DUTCH PEERS trial

Speaker: Professor C. von Birgelen (Enschede, NL)

Thumbnail

Long term outcomes of first and second generation drug-eluting stents in patients with diabetes: a pooled analysis of individual patient data from SORT OUT III, IV and V trials.

Speaker: Doctor M. Maeng (Aarhus, DK)

Thumbnail

Sex-related differences in patients undergoing complex coronary interventions in the era of 2nd generation DES.

Speaker: Doctor B. Vogel (New York, US)

Thumbnail

Access the full session

Long-term outcome of coronary stents and scaffolds

Speakers: Doctor G. Stone, Professor S. Massberg, Professor C. von Birgelen, Doctor M. Maeng, Doctor B. Vogel
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk